Radiosensitization of cancer cells by hydroxychalcones.
Radiation sensitization is significantly increased by proteotoxic stress, such as a heat shock. We undertook an investigation, seeking to identify natural products that induced proteotoxic stress and then determined if a compound exhibited radiosensitizing properties. The hydroxychalcones, 2',5'-dihydroxychalcone (D-601) and 2,2'-dihydroxychalcone (D-501), were found to activate heat shock factor 1 (Hsf1) and exhibited radiation sensitization properties in colon and pancreatic cancer cells. The radiosensitization ability of D-601 was blocked by pretreatment with α-napthoflavone (ANF), a specific inhibitor of cytochrome P450 1A2 (CYP1A2), suggesting that the metabolite of D-601 is essential for radiosensitization. The study demonstrated the ability of hydroxychalcones to radiosensitize cancer cells and provides new leads for developing novel radiation sensitizers.
Pruitt
Rory
R
Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Sasi
Nidhish
N
Freeman
Michael L
ML
Sekhar
Konjeti R
KR
D000230:Adenocarcinoma / Q000532:radiotherapy*; D045744:Cell Line, Tumor; D047188:Chalcones / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000532:radiotherapy*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000532:radiotherapy*; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*
C107497:2',5'-dihydroxychalcone; C552398:2,2'-dihydroxychalcone; D047188:Chalcones; D011838:Radiation-Sensitizing Agents
Phytochemistry. 2004 May;65(10):1389-95
15231412
Radiat Res. 1993 Sep;135(3):387-93
8378532
Lancet. 2000 Apr 1;355(9210):1119-25
10791373
Ann Surg. 2007 Nov;246(5):693-701
17968156
J Cell Physiol. 1997 May;171(2):143-51
9130461
Chem Biol Interact. 2004 Jun 30;148(1-2):57-67
15223357
Hepatogastroenterology. 2002 Nov-Dec;49(48):1666-8
12397760
J Cell Physiol. 1995 Sep;164(3):579-86
7650065
Int J Radiat Biol. 2001 Apr;77(4):399-408
11304434
Eur J Cancer. 2001 Sep;37(13):1587-9
11527682
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1175-80
18207667
Int J Hyperthermia. 2010;26(2):127-35
20146567
Hepatogastroenterology. 2002 Nov-Dec;49(48):1560-2
12397735
Drug Metab Dispos. 2008 Feb;36(2):461-8
18006650
Biochemistry. 1997 Sep 9;36(36):11002-11
9283092
Cancer Res. 2007 Jan 15;67(2):695-701
17234780
Bioorg Med Chem Lett. 2010 Jan 15;20(2):600-2
20005706
Int J Hyperthermia. 2005 Dec;21(8):681-7
16338849
N Engl J Med. 2006 Sep 14;355(11):1114-23
16971718
Int J Hyperthermia. 2006 Feb;22(1):43-60
16423752
Drug Metab Dispos. 2008 Oct;36(10):2104-12
18653743
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3404-9
11248091
J Cell Biol. 1993 Sep;122(6):1267-76
8376462
Bioorg Med Chem Lett. 2007 Dec 15;17(24):6821-4
17980582
Br J Cancer. 1983 Jul;48(1):45-54
6871078
J Biol Chem. 2005 Sep 30;280(39):33097-100
16076838
Eur J Cancer. 2009 Mar;45(5):807-13
19110416
Chem Res Toxicol. 2008 Apr;21(4):805-12
18361512